In Vitro Anti-Cancer Activities in Caco-2 and HCT-116 Cells of Recombinant Cystatin C Prepared by A Pichia Expression System

Journal of Medicinal Food

Volumn 6, Issue 4, 2003, Pages 317-322

  Ogawa, Masahiro ^a   Jing, Hao ^a   Kitts, David D ^a   Nakai, Shuryo ^a   Nakamura, Soichiro ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Biomedical; Cystatin C; Human cancer cell line; Large scale cultivation; Protease; Recombinant DNA

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CYSTATIN; CYSTATIN C; G12W H86V; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; PEPSTATIN; RECOMBINANT CYSTATIN C; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL LYSATE; CELL STRAIN CACO 2; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PICHIA PASTORIS; PRIORITY JOURNAL;

PICHIA; PICHIA PASTORIS;

EID: 1642576016     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662003772519868     Document Type: Article

References (35)

1. Kolkhorst V, Stürzebecher J, Wiederanders B: Inhibition of tumor cell invasion by protease inhibitors: correlation with the protease profile. J Can Res Clin Oncol 1998;124:598-606.
2. Berquin IM, Sloane BF: Cysteine proteases and tumor progression. Perspect Drug Discov Des 1994;2:371-388.
3. Hirai K, Yokoyama M, Asano G, Tanaka S: Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 1999;30:680-686.
4. Johansson N, Ahonen M, Kähäri V-M: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000;57:5-15.
5. Barrett AJ: The cystatins: a new class of peptidase inhibitors. Trends Biochem Sci 1987;12:193-196.
6. Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine protease inhibitors from human urine. Their physiochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 1986;261:11282-11289.
7. Abrahamson M: Cystatins. Methods Enzymol 1994;244:685-700.
8. Koiwa H, Shade RE, Zhu-Salzman K, D'Urzo MP, Murdock LL, Bressan RA, Hasegawa PM: A plant defensive cystatin (soyacystatin) targets cathepsin L-like digestive cysteine proteases (DvCALs) in the larval midgut of western corn rootworm (Diabrotica virgifera virgifera). FEBS Lett 2000;471:67-70.
9. Bjorck L, Grubb A, Kjellen L: Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990;64:941-943.
10. Blankenvoorde MF, Henskens YM, van't Hof W, Veerman EC, Nieuw Amerongen AV: Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin. Biol Chem 1996;377:847-850.
11. Verdot L, Lalmanach G, Vercruysse V, Hoebeke J, Gauthier F, Vray B: Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis. Eur J Biochem 1999;266:1111-1117.
12. Kato T, Imatani T, Miura T, Minaguchi K, Saitoh E, Okuda K: Cytokine-inducing activity of family 2 cystatins. Biol Chem 2000;381:1143-1147.
13. Zhang S, Petro TM: The effect of moderate protein malnutrition on murine T cell cytokine production. Nutr Res 1997;17:51-64.
14. Cross ML: Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Rev 2002;3:115-125.
15. Wlodawer A: Rational approach to AIDS drug design through structural biology. Annu Rev Med 2002;53:595-614.
16. Ogawa M, Nakamura S, Scaman CH, Jing H, Kitts DD, Dou J, Nakai S: Enhancement of proteinase inhibitory activity of recombinant human cystatin C using random-centroid optimization. Biochim Biophys Acta 2002;1599:115-124.
17. Digan ME, Lair SV, Brierley RA, Siegel RS, Williams ME, Ellis SB, Kellaris PA, Provow SA, Craig WS, Veliçelebi G, Harpold MM, Thill GP: Continuous production of a novel lysozyme via secretion from the yeast, Pichia pastoris. BioTechnology 1989;7:160-164.
18. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
19. Jing H, Kitts DD: Chemical and biochemical properties of casein-sugar Maillard reaction products. Food Chem Toxicol 2002;40:1007-1015.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
21. Corticchiato O, Cajot J-F, Abrahamson M, Chan SJ, Keppler D, Sordat B: Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation. Int J Cancer 1992;52:645-652.
22. Barrett A, Kirschke H: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981;80:535-561.
23. de Both NJ, Vermey M, Dinjens WN, Bosman FT: A comparative evaluation of various invasion assays testing colon carcinoma cell lines. Br J Cancer 1999;81:934-941.
24. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-3245.
25. Chauhan SS, Goldstein LJ, Gottesman MM: Expression of cathepsin L in human tumors. Cancer Res 1991;51:1478-1481.
26. Shuja S, Sheahan K, Murnane MJ: Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer 1991;49:341-346.
27. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glössl J, Mach L: Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999;83:526-531.
28. Huber D, Philipp J, Fontana A: Protease inhibitors interfere with the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J Immunol 1992;148:277-284.
29. Wieser R: The transforming growth factor-beta signaling pathway in tumorigenesis. Curr Opin Oncol 2001;13:70-77.
30. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 1998;48:3688-3692.
31. Sexton PS, Cox JL: Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res 1997;7:97-101.
32. Raza SL, Nehring LC, Shapiro SD, Cornelius LA: Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteases. J Biol Chem 2000;275:41243-41250.
33. Kanemoto T, Martin GR, Hamilton TC, Fridman R: Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (matrigel). Invasion Metastasis 1991;11:84-92.
34. Kane SE, Gottesman MM: The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990;1:127-136.
35. Yagel S, Warner AH, Nellans HN, Lala PK, Waghorne C, Denhardt DT: Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res 1989;49:3553-3557.